Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Recipharm AB, commonly referred to as Recipharm, is a leading provider of research and development services within the pharmaceutical industry. Headquartered in Sweden, the company operates across multiple regions, supporting clients globally with innovative R&D solutions. Founded in 2008, Recipharm has established a strong market presence through its focus on developing and manufacturing complex pharmaceutical products.
Specialising in formulation development, clinical trial materials, and manufacturing services, Recipharm’s offerings are distinguished by their commitment to quality and flexibility. The company’s expertise in customised solutions has earned it a notable position in the research and development services sector, making it a trusted partner for pharmaceutical companies seeking innovative drug development support.
68
DitchCarbon score
+35 vs industry average
Recipharm’s score of 68 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Recipharm?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Research Services has below-average carbon intensity
Industry performance
0.198
20182025
The Research Services industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Recipharm's reported carbon emissions
Recipharm, a Swedish research and development services company, reported Scope 1 emissions of 20,956,000 kg CO2e and Scope 2 emissions of 805,000 kg CO2e for 2025. In 2024, their Scope 1 emissions were 22,773,000 kg CO2e and Scope 2 emissions were 1,600,000 kg CO2e. For 2023, Recipharm reported Scope 1 emissions of 24,216,000 kg CO2e, Scope 2 emissions of 3,193,000 kg CO2e, and Scope 3 emissions of 179,203,000 kg CO2e.
Recipharm has set ambitious climate commitments validated by the Science Based Targets initiative (SBTi). They aim to reduce absolute Scope 1 and 2 GHG emissions by 42.1% by 2030 from a 2021 base year. Additionally, Recipharm commits to reducing absolute Scope 3 GHG emissions by 25.0% by 2030 from a 2021 base year, covering categories such as purchased goods and services, fuel and energy-related activities, and upstream transportation. The company also aims to achieve Net Zero Scope 2 GHG emissions by 2030 and Net Zero Scope 1 GHG emissions by 2040, with a broader commitment to Net Zero Scope 3 GHG emissions by 2050. Furthermore, Recipharm plans to increase active annual sourcing of renewable electricity from 93.5% in 2021 to 100% by 2030.
Assessing Recipharm as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Recipharm and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Recipharm’s Climate Goals (2030 & 2050)
3 goals2030
42.1% reduction in Scope 1
Recipharm commits to reduce absolute scope 1 GHG emissions 42.1% by 2030 from a 2021 base year.
On track42.1%
2030
42.1% reduction in Scope 2
Recipharm commits to reduce absolute scope 2 GHG emissions 42.1% by 2030 from a 2021 base year.
On track42.1%
2030
25% reduction in scope 3 total
Recipharm further commits to reduce absolute scope 3 GHG emissions 25.0% by 2030 from a 2021 base year.
Insufficient data25%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Recipharm7 months ago
68
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Recipharm’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more